Publications Pubmed Listings 1. Thompson JT, Rackley MS, and O’Brien TX. Up-regulation of the cardiac homeobox gene Nkx2.5 (CSX) in feline right ventricular pressure overload. Am. J. Physiol. 274 (Heart Circ. Physiol. 43) H1569-H1573, 1998. 2. O’Brien TX, Thompson JT, Schuyler GT, Rackley MS, and Cooper G IV. F1ATPase synthase b-subunit and cytochrome c transcriptional regulation in right ventricular hemodynamic overload and hypertrophically stimulated cardiomyocytes. J. Mol. Cell Cardiol. 31, 167-178, 1999. 3.Muller JG, Thompson JT, Rackley MS, McQuinn TC, Menick DR, O’Brien TX. Co-regulation of Nkx2-5 and serum response factor induced activation of the cardiac sodium-calcium exchanger promoter. Journal of Molecular and Cellular Cardiology, 34:807-821, 2002. 4. Gourdie RG, Harris BS, Bond J, Justus C, Hewett K, O’Brien TX, Thompson RP, Sedmera D. Development of the cardiac pacemaking and conduction system. Birth Defects Research, 69:46-57, 2003. 6. Bastarrika G, Brabham WW, O'Brien TX, Costello P, Schoepf UJ. Dual-source computed tomography assessment of malfunctioning mechanical prosthetic valve. Ann Thorac Surg. 2009;87(5):e50. 8. O’Brien TX. Iron Metabolism, Anemia and Heart Failure. J Am Coll Card ed, 13;58(12):1252-3, 2011
9. Renker M, Nance JW, Schoepf UJ, O’Brien TX, Zwerner PL, Meyer M, Kerl JM, Bauer RW, Fink C, Vogl TJ, Henzler T. Evaluation of heavily heavily calcified vessels with coronary CT angiography: comparison of iterative and filtered back projection image reconstruction. Radiology, 260(2):390-9, 2011. 10. Udelson JE, Bilsker M, Hauptman PJ, Sequerira R, Thomas I, O’Brien TX, Zimmer C, Konstam MA. A multicenter, randomized, double-blind, placebo-controlled study of tolvaptan monotherapy compared to furosemide in patients with heart failure and systolic dysfunction. J Card Fail. 2011 Dec;17(12):973-81 |
